8
Oct
2024

Kexing Biopharm Co.,Ltd.

Exhibitor at CPHI Milan 2024 stand 10B10, Finished Dosage Formulations
About Us

Kexing Biopharm integrates R&D, manufacture, and sales of biopharmaceuticals. 
Its production site offers Recombinant Human Erythropoietin Injection(EPO), Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)Filgrastim, and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. 
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestin...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2022
    On CPHI since
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
View company profile
Contact info
  • +86 10 64272720
  • No.2666,Chuangye Road, Bucun Street, 250215, Jinan, Shandong Province, China
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 10B10, Finished Dosage Formulations